RM

Rahul Moulick

Active Director Director DIN 08270954
DIN 08270954 First appointment Oct 2018 Primary industry Food and Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2018
Shareholding value •••• Premium profile

About Rahul Moulick

Data last updated:

Rahul Moulick is a Director at B. C. Pharmaceuticals Private Limited (since 2018). The company operates in Food and Beverages. B. C. Pharmaceuticals Private Limited reported revenue of ₹73,203 (FY 2021).

DIN 08270954
Primary Designation Director
Industry Food and Beverages
First Appointment 31 Oct 2018
Oldest Company Age 8 yrs
Largest company B. C. Pharmaceuticals Private Limited · ₹73,203 (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Oct 20182018₹73,203 (FY 2021)Active

Board colleagues of Rahul Moulick

Directorship timeline

Open interactive timeline →
B. C. Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rahul Moulick

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rahul Moulick

Rahul Moulick currently holds 1 directorship: B. C. Pharmaceuticals Private Limited (Director, since 31 Oct 2018, revenue ₹73,203 (FY 2021)).

Rahul Moulick was first appointed on 31 Oct 2018 as Director at B. C. Pharmaceuticals Private Limited.

The current boards of Rahul Moulick's companies include Rohit Moulick (B. C. Pharmaceuticals Private Limited), Tushar Kanti Sinha (B. C. Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available